3.238.204.31
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Alagille Syndrome

Oral odevixibat well tolerated, effective in patients with cholestatic liver disease

Oral odevixibat reduced serum bile acids pediatric and improved pruritus in patients with cholestatic liver disease and pruritus were evaluated, according to the results of a Phase 2 study. In this phase 2, open-label, multicenter study, 20 patients, including 13 with progressive familial intrahepatic cholestasis (3 re-entries), 6 with Alagille...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-